ST. LOUIS, Nov. 20, 2013 (GLOBE NEWSWIRE) -- As a reminder to certain stockholders and warrant holders of Stereotaxis, Inc. (Nasdaq:STXS), as well as holders of separately purchased subscription rights, the current rights offering is scheduled to terminate this Thursday, November 21, 2013, at 5:00 pm New York City time.
All payments and documentation required to exercise rights must be received by Broadridge Corporate Issuer Solutions, Inc. (the "Rights Agent") by the termination time, and those rights holders wishing to exercise their rights may need to contact their broker, dealer, customer, bank or other nominee in order to properly exercise their rights. Accordingly, rights holders with any questions regarding exercising their rights should contact the Rights Agent by telephone at (855) 300-4994.
As previously announced, all stockholders and certain warrant holders of Stereotaxis, Inc. as of the record date of October 31, 2013 at 5:00 pm New York City time, received subscription rights. For those interested in purchasing the subscription rights, these rights can be purchased on the NASDAQ Capital Market under the symbol "STXSR," and will continue to be listed until the expiration of the rights offering.For stockholders and certain warrant holders that received subscription rights in connection with the rights offering, 1 subscription right was received for every 1 share held. 1 subscription right allows the purchase of 1/3 a share of common stock at a price of $3.00 per share. As an example, if an investor owned 200 shares of common stock on the record date, the investor would have received 200 subscription rights. The 200 rights would allow for the purchase of 66 shares of commons stock for $3.00 per share (a total of $198 = 3 x 66). As stated above, if holders of subscription rights elect to exercise any rights, the Rights Agent must receive all required documents and payments from the holder prior to the expiration of the rights offering. If the holder's required subscription exercise documentation is received by the Rights Agent after the expiration of the rights offering, Stereotaxis may, in its sole discretion, choose to accept the holder's subscription but will be under no obligation to do so.